Speaker illustration

Doctor Maximilian Hatz

Munich ()

Lack of low-density lipoprotein cholesterol (LDL-C) goal attainment among high-risk patients using high or moderate intensity statin therapy in Germany

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session: Best Posters in new targets in cardiovascular drug assessment

Thumbnail

This platform is supported by

logo Novo Nordisk